Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,538 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort study.
Hirata T, Kawaguchi T, Azuma K, Torii A, Usui H, Kim S, Hayama T, Hirate D, Kawahara Y, Kumihashi Y, Chisaka T, Wako T, Yoshimura A, Miyaji T, Yamaguchi T. Hirata T, et al. Among authors: yoshimura a. BMJ Open. 2023 Nov 22;13(11):e073724. doi: 10.1136/bmjopen-2023-073724. BMJ Open. 2023. PMID: 37993166 Free PMC article.
Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion.
Kitamura K, Kubota K, Ando M, Takahashi S, Nishijima N, Sugano T, Toyokawa M, Miwa K, Kosaihira S, Noro R, Minegishi Y, Seike M, Yoshimura A, Gemma A. Kitamura K, et al. Among authors: yoshimura a. Cancer Chemother Pharmacol. 2013 Feb;71(2):457-61. doi: 10.1007/s00280-012-2026-4. Epub 2012 Nov 21. Cancer Chemother Pharmacol. 2013. PMID: 23178954
Alternating chemotherapy with amrubicin plus cisplatin and weekly administration of irinotecan plus cisplatin for extensive-stage small cell lung cancer.
Noro R, Yoshimura A, Yamamoto K, Miyanaga A, Mizutani H, Minegishi Y, Seike M, Kubota K, Kosaihira S, Hino M, Ando M, Nomura K, Okano T, Kobayashi K, Uematsu K, Gemma A; East Japan Chesters Group. Noro R, et al. Among authors: yoshimura a. Anticancer Res. 2013 Mar;33(3):1117-23. Anticancer Res. 2013. PMID: 23482789 Clinical Trial.
[Iressa (gefitinib)].
Kudoh S, Yoshimura A, Gemma A. Kudoh S, et al. Among authors: yoshimura a. Gan To Kagaku Ryoho. 2003 Aug;30(8):1079-84. Gan To Kagaku Ryoho. 2003. PMID: 12938261 Review. Japanese.
1,538 results